Eko Devices

Executive Summary

Eko Devices is a digital health pioneer transforming cardiac care through AI-powered stethoscopes and software. Its FDA-cleared platform detects heart murmurs, atrial fibrillation, and low ejection fraction, enhancing diagnostic accuracy in physical exams, telehealth, and health system integrations. Founded in 2013 and headquartered in Oakland, CA, the company has established itself as a leader in intelligent auscultation. By combining high-fidelity hardware with machine learning algorithms, Eko enables earlier detection of cardiovascular diseases, reducing reliance on specialist referrals and expensive imaging. With a growing installed base of devices and partnerships across healthcare systems, Eko is positioned to capitalize on the shift toward value-based care and remote patient monitoring. The company's momentum is driven by increasing awareness of heart disease and demand for scalable, AI-enabled diagnostic tools that improve clinical outcomes while lowering costs.

Upcoming Catalysts (preview)

• Q3 2026FDA clearance for new AI algorithm detecting additional cardiac conditions (e.g., valvular disease)75% success
• Q2 2026Major health system or payer partnership for remote monitoring program60% success
• Q4 2026Follow-on funding round or strategic investment from medtech/life sciences firm50% success